Thalidomide-O-amido-PEG2-C2-NH2 TFA
CAS No. 1957235-75-4
Thalidomide-O-amido-PEG2-C2-NH2 TFA( Cereblon Ligand-Linker Conjugates 10 TFA | E3 Ligase Ligand-Linker Conjugates 24 TFA )
Catalog No. M26947 CAS No. 1957235-75-4
Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 81 | Get Quote |
|
10MG | 119 | Get Quote |
|
25MG | 200 | Get Quote |
|
50MG | 296 | Get Quote |
|
100MG | 444 | Get Quote |
|
200MG | 671 | Get Quote |
|
500MG | 1557 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameThalidomide-O-amido-PEG2-C2-NH2 TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
-
DescriptionThalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
SynonymsCereblon Ligand-Linker Conjugates 10 TFA | E3 Ligase Ligand-Linker Conjugates 24 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorH2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1957235-75-4
-
Formula Weight576.482
-
Molecular FormulaC23H27F3N4O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:? H2O : 150 mg/mL (260.20 mM)
-
SMILESOC(=O)C(F)(F)F.NCCOCCOCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Agut J, Sánchez JC, Sacristán A, Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors. Arzneimittelforschung. 1997 Apr;47(4A):447-9.
molnova catalog
related products
-
Oxoglaucine
Oxoglaucine exerts immunomodulatory effect in vivo in a dose-dependent and protocol-dependent manner, it also exhibits significant antiplatelet aggregation activity against rabbit platelets induced by thrombin, arachidonic acid, collagen or platelet activating factor.
-
Bufotenidine
Bufotenidine is a neural tryptaminic receptor blocking agent blocks the effects of both 5-HT and morphine on intestinal motility.
-
CHIR-090
CHIR-090 is a very potent and selective LpxC inhibitor with antibiotic activity.